Projects per year
- 100 - 126 out of 126 results
Search results
-
Active
Global Study of Novel Agents in relapsed and refractory B-NHL with ADCT
Billingham, L., Kearns, P., Siddique, S. & Holt, G.
1/08/21 → 31/01/28
Project: Industry
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
High-Risk Neuroblastoma Study 2 of SIOP-EuropeNeuroblastoma (SIOPEN)
Kearns, P. & Fenwick, N.
NEUROBLASTOMA UK, SOLVING KIDS' CANCER
1/07/20 → 30/06/30
Project: Research
-
TAP: Trials Acceleration Programme (TAP) - Central Trials Unit Hub 2000 - 2024
Craddock, C., Kearns, P. & Fox, S.
1/01/20 → 31/05/27
Project: Research
-
A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours
De Santo, C., Kearns, P., Billingham, L., Middleton, G. & Mussai, F.
Little Princess Trust, Eveson Charitable Trust
1/01/20 → 31/12/24
Project: Research
-
HR-MB: An international High-Risk Medulloblastoma trial
Lawson, A., Kearns, P., Gates, S., Gaunt, P., Pirrie, S., Billingham, L., Homer, V., Jackson, A. & Slade, D.
Cancer Research Uk, SIOP Europe
1/10/18 → 30/09/29
Project: Research
-
Clinical training Award - Cycle 4 - 2018
Kearns, P., Taylor, G. & Gough, R.
1/09/18 → 31/05/24
Project: Research
-
ASTIC-LITE:Autologous Stem Cell Transplantation in refractory Crohn’s disease – Low Intensity Therapy Evaluation
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/08/18 → 31/03/27
Project: Other Government Departments
-
AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomised Trial of Carboplatin vs. Cisplatin for Standard Risk Paediatric and Adult Patiants with Germ Cell Tumours
Kearns, P., Fenwick, N. & Gough, R.
1/06/18 → 30/11/26
Project: Research
-
CRISP: A phase Ib of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies (Study ITCC 053)
Fenwick, N., Kearns, P. & Seaford, E.
Cancer Research Uk, Erasmus Univesitair Medisch Centrum
1/04/18 → 31/10/24
Project: Research
-
-
CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.
Kearns, P., Gatz, S., Liu, W., Gaunt, P., Jackson, A. & Pirrie, S.
Cancer Research Uk, SIOP Europe
1/02/18 → 31/01/28
Project: Research
-
CRUK/17/013 E-smart : European proof of concept therapeutic stratification trial of molecular anomalies in replapsed or refractory tumours in children(E-smart)
Kearns, P., Fenwick, N. & Gough, R.
1/11/17 → 28/02/25
Project: Research
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P., Willcox, B., Lee, S., Middleton, G., Moss, P. & Morton, D.
1/04/17 → 31/12/24
Project: Research
-
SeluDex: A phase IB/II open label study of the MEK-inhibitor selumetinib in combination with dexamethasone for paediatric and adult patients with 2nd relapsed precursor B- or T-ALL
ASTRA ZENECA UK LIMITED, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC), Cancer Research Uk
1/10/16 → 31/12/24
Project: Research
-
Second International Inter-Group Study for Classical Hidgkins Lymphoma in Children (EuroNet-PHL-C2)
1/11/15 → 31/10/27
Project: Research
-
International Collaborative Treatment Protocol for Langerhans Cell Histiocytosis (LCH-IV)
1/10/12 → 31/08/24
Project: Research
-
United Kingdom Acute Lymphoblastic Leukaemia Trial 2010 (UKALL2010)
4/10/10 → 30/09/28
Project: Research